Literature DB >> 19454657

Cutting edge: CD28 engagement releases antigen-activated invariant NKT cells from the inhibitory effects of PD-1.

Jianxiong Wang1, Lu Cheng, Zenebech Wondimu, Mark Swain, Pere Santamaria, Yang Yang.   

Abstract

Costimulatory and coinhibitory signals are important for the maintenance of immune homeostasis both in the steady state and during immune responses. In this study, we explore the relative contributions of these signals to the rapid production of large amounts of cytokines by activated invariant NKT cells (iNKT cells). We find that upon antigenic stimulation, iNKT cells rapidly up-regulate programmed death (PD)-1 and induce high levels of PD ligand 1 and costimulatory molecules on the surface of cognate Ag-presenting dendritic cells and that iNKT cells require a CD28 signal to secrete cytokines in the presence of a PD-1/PD ligand 1 interaction. CD28-deficient iNKT cells synthesized but failed to secrete cytokines during activation, and blockade of the PD-1 pathway restored the ability of CD28-deficient iNKT cells to secrete cytokines. The opposing functions of CD28 and PD-1 thus tightly regulate the unique effector function iNKT cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454657     DOI: 10.4049/jimmunol.0804050

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Immunotherapeutic strategies targeting natural killer T cell responses in cancer.

Authors:  Susannah C Shissler; Dominique R Bollino; Irina V Tiper; Joshua P Bates; Roshanak Derakhshandeh; Tonya J Webb
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

2.  Intranasal but not intravenous delivery of the adjuvant α-galactosylceramide permits repeated stimulation of natural killer T cells in the lung.

Authors:  Amy N Courtney; Prakash Thapa; Shailbala Singh; Ameerah M Wishahy; Dapeng Zhou; Jagannadha Sastry
Journal:  Eur J Immunol       Date:  2011-09-19       Impact factor: 5.532

3.  Contact dependent suppression of CD4 T cell activation and proliferation by B cells activated through IgD cross-linking.

Authors:  Lorena Preciado-Llanes; James B Wing; Rachel A Foster; Jennifer Carlring; Andrew Lees; Robert C Read; Andrew W Heath
Journal:  Immunology       Date:  2014-09-20       Impact factor: 7.397

Review 4.  Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.

Authors:  Mary Speir; Ian F Hermans; Robert Weinkove
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 5.  NKT cell costimulation: experimental progress and therapeutic promise.

Authors:  Marianne J van den Heuvel; Nitan Garg; Luc Van Kaer; S M Mansour Haeryfar
Journal:  Trends Mol Med       Date:  2010-11-17       Impact factor: 11.951

6.  Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.

Authors:  Kevin Durgan; Mohamed Ali; Paul Warner; Yvette E Latchman
Journal:  Cancer Immunol Immunother       Date:  2011-01-15       Impact factor: 6.968

7.  CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.

Authors:  Cheng Ye; Benjamin E Low; Michael V Wiles; Todd M Brusko; David V Serreze; John P Driver
Journal:  J Immunol       Date:  2020-08-31       Impact factor: 5.422

Review 8.  The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity.

Authors:  Suzanne Ostrand-Rosenberg; Lucas A Horn; Samuel T Haile
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

9.  Nur77 controls tolerance induction, terminal differentiation, and effector functions in semi-invariant natural killer T cells.

Authors:  Amrendra Kumar; Timothy M Hill; Laura E Gordy; Naveenchandra Suryadevara; Lan Wu; Andrew I Flyak; Jelena S Bezbradica; Luc Van Kaer; Sebastian Joyce
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-01       Impact factor: 11.205

10.  Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.

Authors:  Sunil K Joshi; Gillian A Lang; Jason L Larabee; T Scott Devera; Lindsay M Aye; Hemangi B Shah; Jimmy D Ballard; Mark L Lang
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.